Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cytomegalovirus vaccines: current status.

S E Starr1

  • 1Joseph Stokes, Jr. Research Institute, Children's Hospital of Philadelphia 19104.

Infectious Agents and Disease
|June 1, 1992
PubMed
Summary

A cytomegalovirus (CMV) vaccine shows promise in preventing severe CMV disease in organ transplant patients. Further research is needed for preventing congenital CMV infections.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Typology of Ohio, USA, tree farmers based upon forestry outreach needs.

Environmental management·2014
Same author

HIV-1 infection of placental cord blood monocyte-derived dendritic cells.

Journal of hematotherapy & stem cell research·2001
Same author

Natural killer cell enumeration and function in HIV-infected and high-risk uninfected adolescents.

AIDS research and human retroviruses·2001
Same author

Patterns of plasma human immunodeficiency virus type 1 RNA response to highly active antiretroviral therapy in infected children.

The Journal of infectious diseases·2000
Same author

Measurement of cytokine secretion, intracellular protein expression, and mRNA in resting and stimulated peripheral blood mononuclear cells.

Clinical and diagnostic laboratory immunology·2000
Same author

T-lymphocyte subsets in HIV-infected and high-risk HIV-uninfected adolescents: retention of naive T lymphocytes in HIV-infected adolescents. The Adolescent Medicine HIV/AIDS Research Network.

Archives of pediatrics & adolescent medicine·2000

Area of Science:

  • Virology
  • Immunology
  • Vaccinology

Background:

  • Cytomegalovirus (CMV) infections pose significant risks in solid organ transplant recipients and during pregnancy.
  • Understanding the natural history of CMV is crucial for developing effective prevention strategies.
  • The Towne live vaccine has demonstrated safety and immunogenicity in healthy adults.

Purpose of the Study:

  • To evaluate the efficacy of the Towne CMV vaccine in preventing severe CMV disease in renal transplant recipients.
  • To explore the potential of CMV vaccines for preventing symptomatic congenital CMV infections.
  • To investigate alternative vaccine approaches, such as recombinant vectors.

Main Methods:

  • A double-blind, placebo-controlled trial was conducted in renal transplant recipients.
  • The study assessed the incidence of severe CMV disease following vaccine administration.
  • Ongoing development of recombinant vectors expressing CMV proteins is underway.

Main Results:

  • Administration of the Towne vaccine significantly reduced the incidence of severe CMV disease in renal transplant recipients.
  • The Towne vaccine was found to be safe and immunogenic in healthy adults.
  • The potential for preventing congenital CMV infection warrants further investigation.

Conclusions:

  • The Towne live vaccine is a viable option for reducing severe CMV disease in solid organ transplant recipients.
  • Further studies are recommended to assess the vaccine's efficacy in preventing congenital CMV infections.
  • Recombinant CMV vaccines represent a promising alternative to live attenuated vaccines.

Related Experiment Videos